P387 Ensuring Excellence: The Data Quality Programme of the cystic fibrosis Registry of IrelandL. Kirwan, R. Doherty, P. O’Regan et al.|Journal of Cystic Fibrosis|2025Cited by 0
P386 Health outcomes for PwCF switching from a CFTR modulator therapy (CFTRm) to elexaftor/tezacaftor/ivacaftor (ETI) compared with those starting on ETI naively. A study using Irish registry dataP. O’Regan, L. Kirwan, R. Doherty et al.|Journal of Cystic Fibrosis|2025Cited by 0